Plus Therapeutics - Investor Summit Group

Plus Therapeutics

Ticker

PSTV

Website

Sector

Healthcare

Tearsheet

Why Invest

A clinical-stage pharmaceutical company focused on developing innovative, targeted radiotherapeutics for adults and children worldwide with rare and difficult-to-treat cancers. Great debt ratio at 0.31 with increasing total assets YoY.